1-6 of 6
George Plitas
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract PO3-04-07: Characterization of response to first-line chemotherapy, trastuzumab, and pertuzumab among patients with de novo metastatic HER2-positive breast cancer

Free
Emanuela Ferraro, Atif Khan, George Plitas, Yuan Chen, Mehnaj Ahmed, Julia An, Chau Dang, Mark Robson, Sarat Chandarlapaty, Shanu Modi, Pedram Razavi, Sherry Shen
Journal: Cancer Research
Cancer Res (2024) 84 (9_Supplement): PO3-04-07.
https://doi.org/10.1158/1538-7445.SABCS23-PO3-04-07
Published: 02 May 2024
View articletitled, Abstract PO3-04-07: Characterization of response to first-line chemotherapy, trastuzumab, and pertuzumab among patients with de novo metastatic HER2-positive breast cancer
Journal Articles

Abstract OT3-15-01: TBCRC-053: P-RAD: A Randomized Study of Preoperative Chemotherapy, Pembrolizumab and No, Low or High Dose RADiation in Node-Positive, HER2-Negative Breast Cancer

Free
Joseph J. Connolly, Laura M. Spring, Alphonse G. Taghian, Michele Gadd, Laura Warren, Ana C. Garrido-Castro, Tari King, Elizabeth A. Mittendorf, Jose P. Leone, Dana L. Casey, Lisa Carey, Tiffany A. Traina, Yara Abdou, Atif Khan, George Plitas, Jean Wright, Cesar Augusto Santa-Maria, Lisa Jacobs, Rachel Blitzblau, E Shelley Hwang, Carey Anders, Ian Krop, Antonio C. Wolff, Alastair M. Thompson, Elyssa Denault, Gaorav Gupta, Alice Ho
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): OT3-15-01.
https://doi.org/10.1158/1538-7445.SABCS22-OT3-15-01
Published: 01 March 2023
View articletitled, Abstract OT3-15-01: TBCRC-053: P-RAD: A Randomized Study of Preoperative Chemotherapy, Pembrolizumab and No, Low or High Dose RADiation in Node-Positive, HER2-Negative Breast Cancer
Journal Articles

Abstract 1928: Prediction of neoadjuvant treatment outcomes with multimodal data integration in breast cancer

Free
Pegah Khosravi, Elizabeth J. Sutton, Justin Jee, Timothy Dalfonso, Christopher J. Fong, Doori Rose, Edaise M. Da Silva, Armaan Kohli, David Joon Ho, Mehnaj S. Ahmed, Danny Martinez, Anika Begum, Elizabeth Zakszewski, Andrew Aukerman, Yanis Tazi, Katja Pinker-Domenig, Sarah Eskreis-Winkler, Atif J. Khan, Edi Brogi, Elizabeth Morris, Sarat Chandarlapaty, George Plitas, Simon Powell, Monica Morrow, Larry Norton, Jianjiong Gao, Mark Robson, Hong Zhang, Sohrab Shah, Pedram Razavi, MSK-MIND Consortium
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 1928.
https://doi.org/10.1158/1538-7445.AM2022-1928
Published: 15 June 2022
View articletitled, Abstract 1928: Prediction of neoadjuvant treatment outcomes with multimodal data integration in breast cancer
Journal Articles

Abstract PD4-05: Axillary recurrence is a rare event in node-positive patients. treated with sentinel node biopsy alone after neoadjuvant chemotherapy: Results of a prospective study

Free
Andrea V Barrio, Giacomo Montagna, Anita Mamtani, Varadan Sevilimedu, Hiram S Cody, III, Mahmoud El-Tamer, Mary L Gemignani, Alexandra S Heerdt, Tracy-Ann Moo, Melissa Pilewskie, George Plitas, Lisa Sclafani, Kimberly J Van Zee, Monica Morrow
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PD4-05.
https://doi.org/10.1158/1538-7445.SABCS20-PD4-05
Published: 15 February 2021
View articletitled, Abstract PD4-05: Axillary recurrence is a rare event in node-positive patients. treated with sentinel node biopsy alone after neoadjuvant chemotherapy: Results of a prospective study
Journal Articles

Abstract PS6-16: Outcomes for metaplastic breast cancer differ by histologic subtype

Free
Audree B Tadros, Varadan Sevilimedu, Emily Zabor, Dilip Giri, Monica Morrow, George Plitas
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PS6-16.
https://doi.org/10.1158/1538-7445.SABCS20-PS6-16
Published: 15 February 2021
View articletitled, Abstract PS6-16: Outcomes for metaplastic breast cancer differ by histologic subtype
Journal Articles

Combined Stimulation with Interleukin-18 and CpG Induces Murine Natural Killer Dendritic Cells to Produce IFN-γ and Inhibit Tumor Growth

Free
Umer I. Chaudhry, T. Peter Kingham, George Plitas, Steven C. Katz, Jesse R. Raab, Ronald P. DeMatteo
Journal: Cancer Research
Cancer Res (2006) 66 (21): 10497–10504.
https://doi.org/10.1158/0008-5472.CAN-06-1908
Published: 01 November 2006
View articletitled, Combined Stimulation with Interleukin-18 and CpG Induces Murine Natural Killer Dendritic Cells to Produce IFN-γ and Inhibit Tumor Growth
Open the PDF for Combined Stimulation with Interleukin-18 and CpG Induces Murine Natural Killer Dendritic Cells to Produce IFN-γ and Inhibit Tumor Growth in another window